MENU

Animal & PDX Models

Technology Transfer Contacts
(technologies available  for licensing)
Note: Links to Patents may require a browser newer than Internet Explorer 9, such as Chrome, Safari, Firefox, Edge, or Internet Explorer 11

 

TECH ID TITLE LEAD INVENTOR CONTACT

02-20

Tg-MISIIR-TAg transgenic mice: a model of epithelial ovarian 

Abstract

Denise Connolly

Natalia Shalginskikh

03-39R

Ovarian Cancer Prone Mice: TgMISIIR -TAg-DR26

Abstract

Denise Connolly

Natalia Shalginskikh

06-34

Mouse model of Spontaneous Mesothelioma (Conditional Bap1 knockout mice)

Abstract

Joseph Testa

Tatiana Venkova

06-37

Pak-1-KO mouse

Abstract

Jonathan Chernoff

Natalia Shalginskikh

07-04

TgMISIIR-TAg-EE73 mice

Abstract

Denise Connolly

Natalia Shalginskikh

98-12

PAK2 fl/fl Mouse

Jonathan Chernoff

Natalia Shalginskikh

99-19

Apc +/Min - FCCC mice: a model for colorectal cancer

Abstract

Margie Clapper 

Natalia Shalginskikh

211-JT

Appl1 knock out mouse

Abstract

Joseph Testa

Tatiana Venkova

223-GE

TetO-p16 t Transgenic Mouse Allowing Inducible Expression of a Potent Cell Cycle Inhibitor

Patent No. US8653324B2; Summary

Greg Enders

Tatiana Venkova

261-JT 

Appl 1 FF mouse model

Abstract

Joseph Testa

Tatiana Venkova

342-JC

p21-Activated Kinase Inhibitor Domain Targeted Transgenic Mouse (ROSA26-LSL-PID)

Published Application No.; Summary

Jonathan Chernoff

Natalia Shalginskikh

368-HH

KRAS 1p53 mouse model

Margie Clapper 

Natalia Shalginskikh

405-JC

Mice with Transgene of iBox Peptide Inhibitor of Group B p21-Activated Kinases (ROSA26-LSL-iBox)

Published Application No.Summary

Jonathan Chernoff

Natalia Shalginskikh

411-DC

Ovarian PDX mouse model and cell lines

PDX Models [PDF]

Denise Connolly

Natalia Shalginskikh

448-DC

TgMISIIR-TAg-DQ62 mice

Abstract

Denise Connolly

Natalia Shalginskikh

472-NJ

Brca1ΔC mouse with a new mutation in the Brca1 gene

Abstract

Neil Johnson

Tatiana Venkova

475-WK

Mouse Models of cystathionine beta-synthase (cbs) deficiency

Abstract

Warren Kruger

Tatiana Venkova

513-JT

Lck-MyrAkt2 transgenic mice. Mice with constitutively activate Akt2 expressed in immature thymic cells, which develop a high incidence of spontaneous thymic lymphomas

Abstract 1

Abstract 2

Joseph Testa

Tatiana Venkova

514-JT

Lck-Dlx5 transgenic mice.  Mice that over-express Dlx5 in immature thymic cells, which develop a high incidence of spontaneous thymic lymphomas.

Abstract

Joseph Testa

Tatiana Venkova

515-JT

Lck-MyrAkt2;Lck-Dlx5 mice.  Mice with constitutively activate Akt2 and overexpression of Dlx5 in immature thymic cells, which develop a very high incidence of spontaneous thymic lymphomas.

Abstract

Joseph Testa

Tatiana Venkova

 

PDX Collection [PDF]

 

Inna Khartchenko

Connect with Fox Chase